# CDC Awards Rotavirus Vaccine Contract

On October 21, 2026, the U.S. Centers for Disease Control and Prevention (CDC) announced a development contract with Micron Biomedical to advance a live-attenuated rotavirus vaccine delivered through the skin using dissolvable microarray technology. The work targets vaccine efficacy and delivery barriers in low- and middle-income countries. The contract value and number were not disclosed, and the announcement does not identify an open solicitation or upcoming procurement milestone.

- This is a funded vaccine R&D collaboration, not a current bid opportunity; the announcement provides no solicitation timeline or contract details for prospective bidders.
- Vaccine development, manufacturing, and global health delivery firms can treat the award as an indicator of CDC-backed interest in needle-free vaccine delivery, while recognizing that no follow-on requirement is announced.
- Contractors assessing related work should distinguish potential future clinical or manufacturing needs from the scope of this development award, which has not been specified publicly.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Grants & Funding
**Published:** October 21, 2026

### Government Entities
- U.S. Centers for Disease Control and Prevention (CDC)

### Vendors
- Micron Biomedical (awardee)

### Key Quotes
> This federal contract to escalate the fight against rotavirus with a novel drug candidate developed by the CDC is a significant milestone for children who are currently at risk of diarrhea-related deaths as well as a recognition of the urgent demand for biotech approaches that address the needs and prefrences of hard to reach populations impacted by healthcare deserts, needle phobia and infrastructure shortages.
> — Steven Damon, Chief Executive Officer of Micron Biomedical

### Sources
- [Micron Biomedical Awarded Federal Vaccine Contract to Fight Rotavirus Through The Skin, Without Needles - BioSpace](https://www.biospace.com/press-releases/micron-biomedical-awarded-federal-vaccine-contract-to-fight-rotavirus-through-the-skin-without-needles) - BioSpace
- [Micron Biomedical Awarded Federal Vaccine Contract to Fight](https://www.globenewswire.com/news-release/2026/10/21/3385366/0/en/micron-biomedical-awarded-federal-vaccine-contract-to-fight-rotavirus-through-the-skin-without-needles.html) - GlobeNewswire